Cargando…
Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
Medication-induced Osteonecrosis of the Jaw (MRONJ) has been reported not only after use of antiresorptive agents (bisphosphonates and denosumab), but also in cancer patients receiving antiangiogenic agents, alone or combined with antiresorptive drugs. We report two cases of MRONJ observed in colore...
Autores principales: | Erovigni, Francesco, Gambino, Alessio, Cabras, Marco, Fasciolo, Antonella, Bianchi, Silvio Diego, Bellini, Elisa, Fusco, Vittorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806959/ https://www.ncbi.nlm.nih.gov/pubmed/29563481 http://dx.doi.org/10.3390/dj4040039 |
Ejemplares similares
-
Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
por: Catania, Gioacchino, et al.
Publicado: (2016) -
Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
por: Migliario, Mario, et al.
Publicado: (2017) -
A multicenter observational study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy
por: Fusco, Vittorio, et al.
Publicado: (2021) -
Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors
por: Wan, Jason T., et al.
Publicado: (2020) -
Osteonecrosis of the jaw (ONJ) in patients who receive Bone Targeting Agents (BTAs): the power of e-learning
por: Nicolatou-Galitis, Ourania, et al.
Publicado: (2018)